Back to Trades
Li Dean Y
DirectorCIK 0001837016
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 7
- Buy transactions
- 0
- Sell transactions
- 1
- Companies
- 2
- Active
- 2025–2026
Li Dean Y, Director, has filed 7 reports across 2 companies, totaling $10.8M in disclosed volume. Sales ($1.2M) outpace purchases ($0). Insider sales are common for diversification and should be read in context. All data sourced from SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
7 loaded
| Jun 22 | RXRX RECURSION PHARMACEUTICALS, INC. | Li Dean Y | Director | Grant | $0 |
| May 7 | MRK Merck & Co., Inc. | Li Dean Y | Executive VP & President, MRL | Other | $0 |
| May 1 | MRK Merck & Co., Inc. | Li Dean Y | Executive VP & President, MRL | Other | $0 |
| Feb 10 | MRK Merck & Co., Inc. | Li Dean Y | Executive VP & President, MRL | Sell | $1.2M |
| Jan 28 | MRK Merck & Co., Inc. | Li Dean Y | Executive VP & President, MRL | Grant | $2.2M |
| Jan 6 | RXRX RECURSION PHARMACEUTICALS, INC. | Li Dean Y | Director | Grant | $0 |
| Oct 3 | RXRX RECURSION PHARMACEUTICALS, INC. | Li Dean Y | Director | Grant | $0 |
7 filings